Independent Financial Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,500
| Closed | -$246K | – | 1357 |
|
|
2025
Q2 | $246K | Hold |
2,500
| – | – | 0.01% | 1117 |
|
|
2025
Q1 | $232K | Hold |
2,500
| – | – | 0.01% | 1044 |
|
|
2024
Q4 | $227K | Hold |
2,500
| – | – | 0.01% | 1035 |
|
|
2024
Q3 | $241K | Hold |
2,500
| – | – | 0.01% | 961 |
|
|
2024
Q2 | $230K | Hold |
2,500
| – | – | 0.01% | 962 |
|
|
2024
Q1 | $230K | Hold |
2,500
| – | – | 0.01% | 905 |
|
|
2023
Q4 | $238K | Hold |
2,500
| – | – | 0.01% | 825 |
|
|
2023
Q3 | $234K | Hold |
2,500
| – | – | 0.02% | 772 |
|
|
2023
Q2 | $229K | Buy |
+2,500
| New | +$205K | 0.02% | 771 |
|
|
2023
Q1 | – | Sell |
-2,500
| Closed | -$209K | – | 840 |
|
|
2022
Q4 | $209K | Hold |
2,500
| – | – | 0.02% | 704 |
|
|
2022
Q3 | $242K | Hold |
2,500
| – | – | 0.02% | 607 |
|
|
2022
Q2 | $263K | Hold |
2,500
| – | – | 0.03% | 542 |
|
|
2022
Q1 | $431K | Hold |
2,500
| – | – | 0.04% | 474 |
|
|
2021
Q4 | $405K | Hold |
2,500
| – | – | 0.03% | 486 |
|
|
2021
Q3 | $373K | Hold |
2,500
| – | – | 0.04% | 455 |
|
|
2021
Q2 | $612K | Hold |
2,500
| – | – | 0.06% | 317 |
|
|
2021
Q1 | $662K | Hold |
2,500
| – | – | 0.09% | 255 |
|
|
2020
Q4 | $733K | Hold |
2,500
| – | – | 0.11% | 215 |
|
|
2020
Q3 | $591K | Hold |
2,500
| – | – | 0.11% | 205 |
|
|
2020
Q2 | $496K | Hold |
2,500
| – | – | 0.11% | 228 |
|
|
2020
Q1 | $459K | Buy |
+2,500
| New | +$445K | 0.13% | 183 |
|
Other funds holding AMED
IA
MCI
HNB
Independent Financial Group's AMED Position: Q3 2025 in Review
Independent Financial Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,500 shares — an estimated $246K sold.
Independent Financial Group first reported a position in AMED in Q1 2020 and held it in 21 quarters. The position peaked at $733K in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Independent Financial Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Independent Financial Group sold 2,500 Amedisys shares in Q3 2025, an estimated $246K.
- Independent Financial Group first reported a position in Amedisys in Q1 2020 and held it in 21 quarters.
- Independent Financial Group's Amedisys position peaked at $733K in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Independent Financial Group's 13F filing for Q3 2025, filed 15 May 2026.